HIGHLIGHTS
- who: August and collaborators from the Hormel Institute, University of Minnesota Twin Cities, United States have published the research work: The correlation between probiotic use and outcomes of cancer patients treated with immune checkpoint inhibitors, in the Journal: (JOURNAL) of 11/06/2023
- how: The results showed that probiotic usage was associated with a decreased risk of poor PFS in cancer patients treated with ICIs although it was of borderline statistical significance (HR 0.585 95% CI 0.328-1.045 p=0.070) . To assess the impact of each study on the overall meta . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.